GESTATIONAL DIABETES MELLITUS: METABOLIC AND CARDIOVASCULAR RISKS FOR THE FETUS

Abstract

Gestational Diabetes Mellitus GDM is a common pregnancy complication characterized by impaired glucose tolerance that develops during gestation. This condition not only affects maternal health but also poses significant metabolic and cardiovascular risks to the developing fetus. The hyperglycemic intrauterine environment can lead to fetal hyperinsulinemia, macrosomia, and alterations in lipid and carbohydrate metabolism, which increase the likelihood of neonatal hypoglycemia, obesity, and long-term metabolic disorders. Additionally, GDM is associated with structural and functional changes in the fetal cardiovascular system, including increased risk of congenital heart defects, vascular dysfunction, and altered hemodynamic parameters. This article examines the pathophysiological mechanisms underlying fetal complications in GDM, emphasizing the role of maternal hyperglycemia, insulin resistance, oxidative stress, and inflammatory mediators. Preventive strategies and management approaches, such as glycemic control, nutritional counseling, pharmacological interventions, and regular prenatal monitoring, are discussed in detail. Early identification and treatment of GDM are crucial to minimizing adverse outcomes for the fetus and improving long-term health trajectories. The article also highlights the importance of interdisciplinary collaboration among obstetricians, endocrinologists, and pediatric specialists to ensure optimal prenatal care. Ultimately, understanding the metabolic and cardiovascular implications of GDM is essential for developing effective preventive and therapeutic strategies to safeguard fetal health.